Skip to main content

Table

From: Ecological and economic impact of ceftazidime and probabilist antibiotherapy limitation strategy in ventilator-associated pneumonia

%

Ps

Ps

Acinetobacter

KES

Staph

 

aeruginosa

cepacia

baumanii

 

aureus

G1

     

   Incidence

19

16.7

6

14.3

19

   CTZ-S

61

85

0

90

-

   AMK-S

55

0

40

83

-

   CPX-S

50

0

0

83

-

   OXA-S

-

-

-

-

30

G2

     

   Incidence

13

11.5

3

23

-

   CTZ-S

85

100

33

94

-

   AMK-S

80

0

33

94

-

   CPX-S

40

0

0

88

-

   OXA-S

-

-

-

-

63

  1. Ps, Pseudomonas; KES, Klebsiella-Enterobacter-Serratia; Staph, Staphyloccocus; CTZ-S, ceftazidime-sensitive; AMK-S, amikacin-sensitive; CPX-S, ciprofloxacin-sensitive; OXA-S, oxacillin-sensitive.
Back to article page

Critical Care

ISSN: 1364-8535